The First Symposium on Subtypes of Muscarinic Receptors, held in 1983, was the first to probe a field ignored for years by all but a few investigators. As a result of research directed at a practical problem of therapeutics, the concept of subtypes of the muscarinic receptor became a reality and a whole field of research was energized into rapid growth. In the short time since the first symposium 4 subtypes have been clearly defined on the basis of pharmacological properties and have been shown to be the products of distinct genes and the sequences, distribution, and coupling mechanisms of 5 muscarinic receptors have been disclosed. The Ninth Symposium will continue the precedents set previously by increasing our basic knowledge of muscarinic receptors and disclosing new agonists and antagonists of potential or demonstrated therapeutic value. The Symposium will be held as a satellite of, and in conjunction with, the annual meeting of the Society of Neurosciences. The major goals are to provide a forum for interaction between individuals who are actively studying muscarinic receptor function and investigators who are actively pursuing the identity and structure of receptor subtypes with technologies evolved from molecular cloning. The broad areas to be covered include: 1) molecular pharmacology regulation and function of muscarinic receptors and interactions with other systems; 2) development, medicinal chemistry and clinical aspects of new, selective agents, particularly with respect to genito-urinary and gastrointestinal systems, and cardiovascular and pulmonary function, and 3) new insights into the role of muscarinic receptors in the central nervous system and their relevance to Alzheimer's disease, schizophrenia, pain and glaucoma. This symposium provides an unique opportunity for interaction between biochemists, physiologists, pharmacologists and neuroscientists who are the leaders in the multidisciplinary approach being taken in the field and young investigators and predoctoral fellows who will present their work in the poster sessions. The Proceedings of the Symposium will be published within 2 to 3 months as a regular issue of Life Sciences and sent free to its thousands of subscribers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Conference (R13)
Project #
1R13NS040268-01
Application #
6159838
Study Section
Special Emphasis Panel (ZNS1-SRB-W (01))
Program Officer
Hamilton, Frank A
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$14,825
Indirect Cost
Name
Boston University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118